Comparer des méthodes

	FACT-Ovarian : Évaluation fonctionnelle des thérapies anticancéreuses	FACT-Lung : Évaluation fonctionnelle des thérapies anticancéreuses
Domaine	Oncologie	Oncologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2001	1995
Auteur d'origine	Basen-Engquist, K., et al. (built on Cella, D. F. FACT-G framework)	David F. Cella, Ph.D.
Type	Self-report questionnaire	Self-report questionnaire
Source fondatrice	Basen-Engquist, K., Bodurka, D. C., Lu, H., Sill, M. W., Thaker, P. H., Deavers, M. T., et al. (2001). Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) quality of life instrument. Gynecol Oncol, 89(3), 478–488.	Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153.
Alias	FACT-O	FACT-L
Apparentées	5	5
Résumé	The FACT-Ovarian (FACT-O) is a disease-specific quality-of-life measure for women with ovarian cancer, integrating the 27-item FACT-G core with a 12-item ovarian-specific subscale addressing cancer-related symptoms, sexual function, abdominal distension, and treatment side effects. Validated by Basen-Engquist et al. in 2001, it is a standard endpoint in ovarian cancer clinical trials and supportive care research.	The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden.